We are building the universal biomarker testing platform of the future.
Profile all clinically relevant biomarkers at once with our (MAD)2 technology.
Our Multi-molecule Affinity Assay with Docker Displacement (MAD)2 technology enables a single testing platform for the diversity of biomarkers in a clinical sample.
Reduce laboratory complexity and improve patient outcomes with our universal biomarker testing platform.
Stay in touch.
Sign up to receive news and updates.